Metraipolis › archive › dc_f2ab54c45e65

Preclinical evidence and therapeutic perspectives on carnosine for the treatment of neurodegenerative disorders — Europe PMC PMID:41527663

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41527663
DOI
10.3934/neuroscience.2025025
License (as archived)
solo-consultazione
Archived
2026-11-09T04:08:49.541Z
SHA-256 of the archived text
3c33ae8608f12513cb8365fc07d5a35bbdf0ed167abf1aa73017da7e61af3c56
Stable URL of this page
https://metraipolis.com/documento/dc_f2ab54c45e65

How to cite

Preclinical evidence and therapeutic perspectives on carnosine for the treatment of neurodegenerative disorders — Europe PMC PMID:41527663 — Europe PMC (en), https://europepmc.org/article/MED/41527663 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2ab54c45e65 (Metraipolis archive dc_f2ab54c45e65, sha256 3c33ae8608f12513cb8365fc07d5a35bbdf0ed167abf1aa73017da7e61af3c56)
BibTeX
@misc{dcf2ab54c45e65,
  title = {Preclinical evidence and therapeutic perspectives on carnosine for the treatment of neurodegenerative disorders — Europe PMC PMID:41527663},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41527663},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2ab54c45e65; sha256 3c33ae8608f12513cb8365fc07d5a35bbdf0ed167abf1aa73017da7e61af3c56},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41527663. Agents can read the archived copy with the MCP tool read_document.